Ambien CR(R) (zolpidem Tartrate Extended-release) CIV Tablets Improved Insomnia And Daily Functioning In Patients With Depressive Disorder
Sanofi-aventis
announced results from a new study that showed Ambien CR(R) (zolpidem
tartrate extended-release) CIV tablets 12.5 mg provided significant
improvement in sleep onset, sleep maintenance and total sleep time over 8
weeks in patients with co-morbid insomnia and major depressive disorder
(MDD) who were administered a Selective Serotonin Reuptake Inhibitor (SSRI)
for depression. Ambien CR also improved sleep-related next-day functioning
measures. This data was presented at the SLEEP 2008 22nd Annual Meeting of
the Buy zithromax without prescription Associated Professional Sleep Societies (APSS).
Thomas Roth, PhD, director of the Sleep Disorders and Research Center
at Henry Ford Hospital, states, "The results of this study demonstrate that
Ambien CR can be considered a viable treatment option for the insomnia MDD
patients experience and help them get the good night’s sleep they need to
improve their next-day functioning."
Ambien CR Improved Sleep Quality and Sleep Impact on Daily Activities
in MDD Patients
Total sleep time was increased in the Ambien CR group throughout the
study. At Week eight, patients reporting sleeping an average of 101 minutes
more than baseline compared to placebo-treated patients who reported
sleeping an average 64 minutes more (PBuy viagra pills | generic propecia online buy | Buy generic levitra
Tags: depression, health